title: An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions.
abstract: This study was designed to evaluate the effects of specific and potent cathepsin inhibitors on osteoclastic resorptive functions in vitro by means of a novel ultrastructural assay system. Mouse bone marrow cell-derived osteoclasts were suspended on dentine slices and cultured for 48 hours in the presence of either E-64 (a generalized cysteine proteinase inhibitor) or Z-Phe-Phe-CHN2 (a selective cathepsin L inhibitor). After the removal of cultured osteoclasts, co-cultured dentine slices were examined using electron microscopy: backscattered (BSEM), scanning (SEM), and atomic force (AFM). In morphometric analyses of BSEM images, there were no significant differences in the areas of demineralized dentine surfaces between control and inhibitor-treated groups, suggesting that cathepsin inhibitors had no effect on dentine demineralization by cultured osteoclasts. However, in SEM and AFM observations, both inhibitors remarkably reduced to the same extent, the formation of deep resorption lacunae on dentine slices that had resulted from degradation of matrix collagen. In addition, Z-Phe-Phe-CHN2 treatment produced deeper, ring-like grooves with little collagen exposure in shallow resorption lacunae. These results strongly suggest that (1) cathepsins released by osteoclasts are involved in the formation of deep resorption lacunae, and (2) cathepsin L plays a key role in bone resorption.
authors.affiliation: Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Debari
authors.forename: T
authors.initials: T
authors.lastname: Sasaki
authors.forename: N
authors.initials: N
authors.lastname: Udagawa
authors.forename: B R
authors.initials: BR
authors.lastname: Rifkin
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001862:Bone Resorption; D002403:Cathepsins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002478:Cells, Cultured; D003094:Collagen / Q000187:drug effects; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D003804:Dentin / Q000648:ultrastructure; D003978:Diazomethane / Q000031:analogs & derivatives* / Q000494:pharmacology; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051379:Mice; D008855:Microscopy, Electron, Scanning; D010010:Osteoclasts / Q000502:physiology* / Q000648:ultrastructure; D017001:Tooth Demineralization / Q000139:chemically induced
chemical_list: D015853:Cysteine Proteinase Inhibitors; D003978:Diazomethane; C031947:benzyloxycarbonylphenylalanylphenylalanine diazomethyl ketone; D003094:Collagen; D002403:Cathepsins; D007930:Leucine; C024974:E 64